Trials / Unknown
UnknownNCT00854633
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Agennix · Industry
- Sex
- All
- Age
- 1 Minute – 24 Hours
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety, toxicity and efficacy of talactoferrin in reducing the incidence of all nosocomial infections in prematurely-born infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Talactoferrin | Enteral, 150 mg/kg twice per day |
| DRUG | Placebo | Oral, twice per day |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2012-03-01
- Completion
- 2012-12-01
- First posted
- 2009-03-03
- Last updated
- 2012-03-15
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00854633. Inclusion in this directory is not an endorsement.